Semaglutide remains on the agency’s drug shortage list, but all FDA-approved forms of the drug are no longer labeled ...

In fact, one clinical trial indicated that only about 86% of the more than 800 participants achieved “clinically significant” weight loss after taking semaglutide, sold under the brands Ozempic and ...

Results were announced from a phase 3 clinical trial evaluating subcutaneous semaglutide in overweight patients with cardiovascular disease.

Recent studies have found that Ozempic could lead to more muscle mass loss than traditional weight loss methods.

Since Eli Lilly's Mounjaro and Novo Nordisk's Wegovy and Ozempic fell into shortage in late 2022, compounding pharmacies have been manufacturing their respective generics, tirzepatide and semaglutide.

Semaglutide offers a multifaceted approach to type 2 diabetes treatment, enhancing insulin release and reducing blood sugar ...

Customs and Border Protection agents in Cincinnati have seized shipments of unapproved weight loss drugs arriving from ...

Struggling with weight loss? Layton Weight Loss Clinic has the solution! With Semaglutide and Tirzepitide treatments supervised by medical experts, ...

Excitement is building around a new weight loss drug, CagriSema, which is expected to surpass the effects of popular drugs ...

The pharmaceutical company says data on 10 deaths and more than 100 hospitalizations comes from the FDA’s adverse event reporting database for semaglutide — the key ingredient in Ozempic and Wegovy, ...

The use of semaglutide, a glucagon-like peptide 1 receptor agonist (GLP-1 RA), is not associated with an increased risk for ...

Novo Nordisk, the maker of Ozempic, reported that compounded versions of semaglutide, the main ingredient in Ozempic and ...